Home

Dichte Biografie Lügen cfdna sequencing T. Interaktion Monica

Frontiers | Nanopore sequencing of clonal IGH rearrangements in cell-free  DNA as a biomarker for acute lymphoblastic leukemia
Frontiers | Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia

Diagnostics | Free Full-Text | Tracing the Origin of Cell-Free DNA  Molecules through Tissue-Specific Epigenetic Signatures
Diagnostics | Free Full-Text | Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures

Detecting cell-of-origin and cancer-specific methylation features of cell-free  DNA from Nanopore sequencing | Genome Biology | Full Text
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing | Genome Biology | Full Text

Billy Lau: Single molecule methylation profiles of cell-free DNA in cancer  with nanopore sequencing - YouTube
Billy Lau: Single molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing - YouTube

ChIP-seq of plasma cell-free nucleosomes identifies gene expression  programs of the cells of origin | Nature Biotechnology
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin | Nature Biotechnology

Fragmentation patterns and personalized sequencing of cell‐free DNA in  urine and plasma of glioma patients | EMBO Molecular Medicine
Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients | EMBO Molecular Medicine

Sequencing of 5hmC in cfDNA. (A) General procedure of cell-free 5hmC... |  Download Scientific Diagram
Sequencing of 5hmC in cfDNA. (A) General procedure of cell-free 5hmC... | Download Scientific Diagram

Leveraging the Fragment Length of Circulating Tumour DNA to Improve  Molecular Profiling of Solid Tumour Malignancies with Next-Generation  Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision  Oncology? | SpringerLink
Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology? | SpringerLink

Profiling disease and tissue-specific epigenetic signatures in cell-free DNA
Profiling disease and tissue-specific epigenetic signatures in cell-free DNA

Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its  Tissues-Of-Origin: Cell
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin: Cell

Cell-free DNA TAPS provides multimodal information for early cancer  detection | Science Advances
Cell-free DNA TAPS provides multimodal information for early cancer detection | Science Advances

Analytical and Clinical Validation of a Digital Sequencing Panel for  Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA  | PLOS ONE
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA | PLOS ONE

CIMB | Free Full-Text | Current and Future Perspectives of Cell-Free DNA in  Liquid Biopsy
CIMB | Free Full-Text | Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy

Towards detecting low-frequency variants in highly fragmented circulating cell-free  DNA
Towards detecting low-frequency variants in highly fragmented circulating cell-free DNA

Griffin: Framework for clinical cancer subtyping from nucleosome profiling  of cell-free DNA | medRxiv
Griffin: Framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA | medRxiv

Sensitive detection of stage I lung adenocarcinoma using plasma cell-free  DNA breakpoint motif profiling - eBioMedicine
Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling - eBioMedicine

Frontiers | Characterization of Cell Free Plasma Methyl-DNA From  Xenografted Tumors to Guide the Selection of Diagnostic Markers for  Early-Stage Cancers
Frontiers | Characterization of Cell Free Plasma Methyl-DNA From Xenografted Tumors to Guide the Selection of Diagnostic Markers for Early-Stage Cancers

Single-molecule sequencing reveals a large population of long cell-free DNA  molecules in maternal plasma | PNAS
Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma | PNAS

Frontiers | Signatures Beyond Oncogenic Mutations in Cell-Free DNA  Sequencing for Non-Invasive, Early Detection of Cancer
Frontiers | Signatures Beyond Oncogenic Mutations in Cell-Free DNA Sequencing for Non-Invasive, Early Detection of Cancer

Size profile of cell-free DNA: A beacon guiding the practice and innovation  of clinical testing
Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric  cancers with low mutational burden | Nature Communications
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden | Nature Communications

Epigenetic analysis of cell-free DNA by fragmentomic profiling | PNAS
Epigenetic analysis of cell-free DNA by fragmentomic profiling | PNAS

A cell-free DNA metagenomic sequencing assay that integrates the host  injury response to infection | PNAS
A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infection | PNAS

Simultaneous monitoring of disease and microbe dynamics through plasma DNA  sequencing in pediatric patients with acute lymphoblastic leukemia |  Science Advances
Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia | Science Advances

Ha Lab - Research
Ha Lab - Research